This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Andre Herbelin
Introduction
Andre Herbelin is a notable inventor based in Malakoff, France. He has made significant contributions to the field of medical research, particularly in the treatment of auto-immune diseases. His work has implications for various conditions, including insulin-dependent diabetes mellitus.
Latest Patents
Herbelin holds a patent for the "Use of IL-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular." This patent discloses the use of interleukin 7 or T cells pre-incubated in the presence of IL-7 for preparing a drug or pharmaceutical composition aimed at treating auto-immune diseases. The focus is particularly on auto-immune diseases induced by a defect in CD4+ T cell immunoregulation. He has 1 patent to his name.
Career Highlights
Andre Herbelin is associated with Sanofi-Synthelabo, a leading global healthcare company. His role in the company has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Herbelin has collaborated with esteemed colleagues such as Jean Francois Bach and Jean Marc Gombert. These collaborations have further enriched his research and innovation efforts.
Conclusion
Andre Herbelin's work exemplifies the impact of innovative research in the medical field. His contributions, particularly in the treatment of auto-immune diseases, highlight the importance of continued exploration and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile